These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 20868638

  • 1. Extract of Ginkgo biloba treatment for tardive dyskinesia in schizophrenia: a randomized, double-blind, placebo-controlled trial.
    Zhang WF, Tan YL, Zhang XY, Chan RC, Wu HR, Zhou DF.
    J Clin Psychiatry; 2011 May; 72(5):615-21. PubMed ID: 20868638
    [Abstract] [Full Text] [Related]

  • 2. Extract of Ginkgo biloba for Tardive Dyskinesia: Meta-analysis of Randomized Controlled Trials.
    Zheng W, Xiang YQ, Ng CH, Ungvari GS, Chiu HF, Xiang YT.
    Pharmacopsychiatry; 2016 May; 49(3):107-11. PubMed ID: 26979525
    [Abstract] [Full Text] [Related]

  • 3. Brain-derived neurotrophic factor levels and its Val66Met gene polymorphism predict tardive dyskinesia treatment response to Ginkgo biloba.
    Zhang XY, Zhang WF, Zhou DF, Chen DC, Xiu MH, Wu HR, Haile CN, Kosten TA, Kosten TR.
    Biol Psychiatry; 2012 Oct 15; 72(8):700-6. PubMed ID: 22695185
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia.
    Zhang XY, Zhou DF, Zhang PY, Wu GY, Su JM, Cao LY.
    J Clin Psychiatry; 2001 Nov 15; 62(11):878-83. PubMed ID: 11775047
    [Abstract] [Full Text] [Related]

  • 5. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings.
    Mix JA, Crews WD.
    Hum Psychopharmacol; 2002 Aug 15; 17(6):267-77. PubMed ID: 12404671
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of extract of Ginkgo biloba as an adjunct therapy in chronic schizophrenia: A systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis.
    Chen X, Hong Y, Zheng P.
    Psychiatry Res; 2015 Jul 30; 228(1):121-7. PubMed ID: 25980333
    [Abstract] [Full Text] [Related]

  • 7. An examination of the efficacy of Ginkgo biloba extract EGb761 on the neuropsychologic functioning of cognitively intact older adults.
    Mix JA, Crews WD.
    J Altern Complement Med; 2000 Jun 30; 6(3):219-29. PubMed ID: 10890330
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial.
    Zhang XY, Zhou DF, Cao LY, Wu GY.
    Psychopharmacology (Berl); 2006 Sep 30; 188(1):12-7. PubMed ID: 16906395
    [Abstract] [Full Text] [Related]

  • 10. [Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication].
    Blume J, Kieser M, Hölscher U.
    Vasa; 1996 Sep 30; 25(3):265-74. PubMed ID: 8967154
    [Abstract] [Full Text] [Related]

  • 11. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial.
    Kanowski S, Hoerr R.
    Pharmacopsychiatry; 2003 Nov 30; 36(6):297-303. PubMed ID: 14663654
    [Abstract] [Full Text] [Related]

  • 12. Ginkgo biloba for Tardive Dyskinesia and Plasma MnSOD Activity: Association with MnSOD Ala-9Val Variant: A Randomized, Double-blind Trial.
    Wang D, Tian Y, Chen J, Zhu R, Li J, Zhou H, Chen D, Wang L, Kosten TR, Zhang XY.
    Curr Neuropharmacol; 2024 Nov 30; 22(14):2443-2452. PubMed ID: 38919004
    [Abstract] [Full Text] [Related]

  • 13. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF.
    JAMA; 2024 Nov 30; 278(16):1327-32. PubMed ID: 9343463
    [Abstract] [Full Text] [Related]

  • 14. Ginkgo biloba special extract EGb 761 in generalized anxiety disorder and adjustment disorder with anxious mood: a randomized, double-blind, placebo-controlled trial.
    Woelk H, Arnoldt KH, Kieser M, Hoerr R.
    J Psychiatr Res; 2007 Sep 30; 41(6):472-80. PubMed ID: 16808927
    [Abstract] [Full Text] [Related]

  • 15. The effect of extract of ginkgo biloba addition to olanzapine on therapeutic effect and antioxidant enzyme levels in patients with schizophrenia.
    Atmaca M, Tezcan E, Kuloglu M, Ustundag B, Kirtas O.
    Psychiatry Clin Neurosci; 2005 Dec 30; 59(6):652-6. PubMed ID: 16401239
    [Abstract] [Full Text] [Related]

  • 16. A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia.
    Le Bars PL, Kieser M, Itil KZ.
    Dement Geriatr Cogn Disord; 2000 Dec 30; 11(4):230-7. PubMed ID: 10867450
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R, Bachinskaya N, Korczyn AD, Vakhapova V, Tribanek M, Hoerr R, Napryeyenko O, GOTADAY Study Group.
    Int J Geriatr Psychiatry; 2011 Nov 30; 26(11):1186-94. PubMed ID: 21140383
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI, Preuss UW, Wong JW, Hoerr R, Kaschel R, Bachinskaya N, GIMCIPlus Study Group.
    Int J Geriatr Psychiatry; 2014 Oct 30; 29(10):1087-95. PubMed ID: 24633934
    [Abstract] [Full Text] [Related]

  • 19. Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial.
    Napryeyenko O, Borzenko I, GINDEM-NP Study Group.
    Arzneimittelforschung; 2007 Oct 30; 57(1):4-11. PubMed ID: 17341003
    [Abstract] [Full Text] [Related]

  • 20. KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
    Hauser RA, Factor SA, Marder SR, Knesevich MA, Ramirez PM, Jimenez R, Burke J, Liang GS, O'Brien CF.
    Am J Psychiatry; 2017 May 01; 174(5):476-484. PubMed ID: 28320223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.